The first volume of this series features 6 chapters that cover a variety of topics including:
-Angiotensin blockers
-Agents targeting advanced glycation end products
-Drugs and the peroxisome proliferator activated receptors
-Topical Drugs for diabetic complications
-Research on Liraglutide
-Research on MicroRNAs as agents for diabetes treatment
Loading...
Loading...

